Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04843969
Other study ID # 421-0318
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date February 20, 2018
Est. completion date January 31, 2022

Study information

Verified date April 2021
Source McGill University Health Centre/Research Institute of the McGill University Health Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Interventions to disrupt memory reconsolidation have held promise for the treatment of stress- and anxiety-related disorders. In the present study, the investigators will examine whether an intervention based on these principles, called memory updating, could be adapted for reward-seeking behaviors. To test this, non-treatment seeking tobacco smokers will be exposed to smoking cues and/or stress, two stimuli known to trigger smoking. It is predicted that exposure to a stress task will enhance the cues' motivational salience and yield greater susceptibility to the memory updating procedure. As an add-on, the investigators will examine COVID-associated changes in substance use and whether participants in the memory updating groups might be more resilient to these effects. It is predicted that the changes in substance use will depend on whether the substances are used primarily in social settings.


Description:

Non-treatment seeking cigarette dependent smokers will be randomized to one of four testing conditions: 1) a non-stressful task followed by neutral cues, 2) the non-stressful task followed by smoking cues, 3) a stressful task followed by neutral cues, or 4) the stressful task followed by smoking cues. Ten minutes after the intervention, participants will undergo a 60-minute extinction procedure consisting of smoking-related videos, images and smoking paraphernalia. Cue reactivity test sessions will take place 24 hours, 2 weeks and 6 weeks following the intervention. COVID-associated changes in substance use will be quantified over three telephone interviews: one at the end of March / beginning of April 2020 (at the start of the pandemic), one at the end of April / beginning of May, and a final one which will be instituted if feasible once the infection rates and social distancing policies have decreased.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 76
Est. completion date January 31, 2022
Est. primary completion date May 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Scoring 5 or higher on the Fagerström Test for Cigarette Dependence - Willingness to abstain from smoking for 4 hours prior to each laboratory visit Exclusion Criteria: - Currently using cigarette cessation products - Endocrinological problems - Significant mental or physical health conditions - Pregnancy

Study Design


Intervention

Behavioral:
Stress induction
Exposure to a psychosocial stressor
Control stress exposure
Exposure to a control task (no stress)
Cue induction
Exposure to a smoking-related task
Neutral cue exposure
Exposure to neutral cues

Locations

Country Name City State
Canada McGill University Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Marco Leyton

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in stress- and/or cue-induced mood during the intervention and at test sessions 1, 2 and 3 Participants will be asked to complete a mood questionnaire at several time points during the intervention and at test sessions 1, 2 and 3 Multiple time points during the intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention
Other Change in cigarette use over the course of the procedure as a function of personality factors, childhood trauma, perceived stress, mood and/or cigarette withdrawal Participants will be asked to complete self-report questionnaires about their personality traits, traumatic childhood experiences, perceived stress, current mood states and cigarette withdrawal symptoms Multiple time points at baseline, during the intervention, at test sessions (24 hours, 2 weeks and 6 weeks post-intervention) and telephone follow-ups (6 months post-intervention)
Primary Change in cigarettes smoked per day from the pre-intervention baseline to test sessions 2 and 3 given two and six weeks post-intervention A journal is given to participants to record their cigarette use behaviour every day for a month and a half At the end of test session 1 (24 hours post-intervention), participants will receive a journal to record their daily smoking behaviour. They are asked to keep this journal until test session 3 (6 weeks post-intervention).
Secondary Change in smoking cue-induced cigarette cravings from the pre-intervention baseline to test session 2 Participants will be asked to complete craving and urge to smoke questionnaires at several time points throughout the study sessions Multiple times points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention.
Secondary Change in smoking cue-induced cigarette cravings from the pre-intervention baseline to test session 3 Participants will be asked to complete craving and urge to smoke questionnaires at several time points throughout the study sessions Multiple times points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention.
Secondary Change in smoking cue-induced heart rate responses from the pre-intervention baseline to test session 2 Participants' heart rate will be measured through the use of a polar belt at several time points during the study sessions Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention
Secondary Change in smoking cue-induced heart rate responses from the pre-intervention baseline to test session 3 Participants' heart rate will be measured through the use of a polar belt at several time points during the study sessions Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention
Secondary Change in smoking cue-induced skin conductance responses from the pre-intervention baseline to test session 2 Participants' skin conductance will be measured through the use of electrodes on their index and middle fingers at several time points during the study sessions Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention
Secondary Change in smoking cue-induced skin conductance responses from the pre-intervention baseline to test session 3 Participants' skin conductance will be measured through the use of electrodes on their index and middle fingers at several time points during the study sessions Multiple time points during the baseline, intervention and test sessions at 24 hours, 2 weeks and 6 weeks post-intervention
Secondary Change in tobacco and other substance use patterns from the pre-COVID-19 baseline to during COVID-19 Participants will be asked to report the quantity of cigarettes and/or other substances they have consumed recently Multiple time points at baseline (before the pandemic), at the start of the pandemic, and during the pandemic
Secondary Change in tobacco and other substance use patterns from the pre-COVID-19 baseline to post-COVID-19 Participants will be asked to report the quantity of cigarettes and/or other substances they have consumed recently At baseline (before the pandemic) and through study completion, an average of 1 year
Secondary Change in tobacco and other substance use patterns during the COVID-19 pandemic to post-COVID-19 Participants will be asked to report the quantity of cigarettes and/or other substances they have consumed recently Multiple time points during the pandemic and through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Recruiting NCT06033599 - Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement Phase 3
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability N/A
Completed NCT01311830 - Enhancing Smoker Utilization of the Minnesota Quitline Through Support Persons N/A
Completed NCT04566198 - Smoking in the Paris Fire Brigade and Comparison According to the Type of Service (Permanent or On-call)
Completed NCT04107779 - Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS N/A
Completed NCT05092919 - The Effect of Sweet Flavoring on the Rewarding and Reinforcing Value of Cigarillo Use Among Young Adults Early Phase 1
Terminated NCT05274217 - Journey of Transformation Curriculum for Native American Adolescents N/A
Enrolling by invitation NCT06042361 - Enhancing Equity in Smoke-free Housing N/A
Recruiting NCT05380765 - Developing a Positive Approach to Substance Use Prevention in North American Indian Adolescents N/A
Completed NCT03235713 - EMA for Tobacco Control Policy Research
Withdrawn NCT03352635 - Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking Clinical and Biomarkers Core N/A
Completed NCT03151421 - Air Quality Feedback to Reduce Second-hand Smoke (SHS) Exposure in the Home N/A
Completed NCT03446170 - Effect of Cigarette Pack Warnings and Packaging Among Young Adult Smokers N/A
Completed NCT04104152 - CSD190203: A Study to Determine Subject Puffing Patterns of an Electronic Nicotine Delivery System in an Ambulatory Setting N/A
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Recruiting NCT04429568 - THC Crossover Study N/A
Completed NCT04632030 - Shrinking the Size of the Tobacco Power Wall N/A